miR-495 Enhances the Sensitivity of Non-Small Cell Lung Cancer Cells to Platinum by Modulation of Copper-Transporting P-type Adenosine Triphosphatase A (ATP7A)

miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3

(2012) Zhengrong Li et al.   CANCER LETTERS

Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC)

(2012) Zhuang-hua Li et al.   Journal of Translational Medicine

miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia

(2012) X. Jiang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3

(2011) Bing Feng et al.   CANCER

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP

(2011) Wei Zhu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Hypoxia-inducible MicroRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma

(2011) Qiao Ying et al.   HEPATOLOGY

miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans

(2011) Pai-Sheng Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2

(2011) Wei Zhu et al.   MEDICAL ONCOLOGY

miR-495 is upregulated by E12/E47 in breast cancer stem cells and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1

(2011) W W Hwang-Verslues et al.   ONCOGENE

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

(2011) A Holleman et al.   ONCOGENE

A miR-200b/200c/429-Binding Site Polymorphism in the 3′ Untranslated Region of the AP-2α Gene Is Associated with Cisplatin Resistance

(2011) Yuan Wu et al.   PLoS One

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis

(2010) Linlang Guo et al.   EUROPEAN JOURNAL OF CANCER

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

(2010) Igor P. Pogribny et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells

(2010) Bo Song et al.   Molecular Cancer

Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2

(2009) K. K.W. To et al.   MOLECULAR CANCER THERAPEUTICS

Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells

(2008) Ganna V Kalayda et al.   BMC CANCER

MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN

(2008) H. Yang et al.   CANCER RESEARCH

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

(2008) Lin Xia et al.   INTERNATIONAL JOURNAL OF CANCER

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

(2008) O. Kovalchuk et al.   MOLECULAR CANCER THERAPEUTICS